Patterns of Care and Survival of Chinese Glioblastoma Patients in the Temozolomide Era: A Hong Kong Population-Level Analysis over a 14-year Period - HKNOS
Skip to content
HKNOS
The Hong Kong Neuro-Oncology Society
Home
Members/Healthcare professionals
objectives / council members / memberships / contact us
Education Centre
中
© 2025 The hong kong neuro-oncology society. all rights reserved.
HKNOS
The Hong Kong Neuro-Oncology Society
DONATIONS
中

Patterns of Care and Survival of Chinese Glioblastoma Patients in the Temozolomide Era: A Hong Kong Population-Level Analysis over a 14-year Period

Post navigation

The 2021 WHO Classification of Tumors of the Central Nervous System: clinical implications
Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study Repeat resection for recurrent glioblastoma in the temozolomide era: a real-world multi-centre study

Recent Posts

  • [HKNOS Public Events] 【腦腫瘤關注月】甚麼是腦膜瘤?|鄒淑韻醫生
  • [HKNOS Sponsorship] 20th Annual Meeting of the Asian Society for Neuro-Oncology (ASNO 2025)
  • [Events outside HKNOS] The 18th Annual Meeting of the Korean Society of Medical Oncology & 2025 International Conference
  • HKNOS Annual Scientific Meeting 2024
  • Events outside HKNOS: HSBC-Brain Tumors 2025 18-19 January 2025

Categories

  • Event
  • Events outside HKNOS
  • General Public
  • Sponsorship
  • Uncategorized
The Hong Kong Neuro-Oncology Society
香港神經腫瘤學會